Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor

Title
Cellular androgen content influences enzalutamide agonism of F877L mutant androgen receptor
Authors
Keywords
genitourinary cancers: prostate, hormone signaling and inhibitors, regulation of gene expression in drug resistance, androgen receptor mutations, BET bromodomain inhibition
Journal
Oncotarget
Volume 7, Issue 26, Pages -
Publisher
Impact Journals, LLC
Online
2016-06-04
DOI
10.18632/oncotarget.9816

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started